Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth

Universidade Federal do Ceara

Status and phase

Unknown

Phase 2

Conditions

Dental Pulp Necrosis

Treatments

Drug: chlorexidine

Study type

Interventional

Funder types

Other

Identifiers

NCT00624572

CHX0784

Details and patient eligibility

About

The purpose of this study is to evaluate the action of the chlorexidine as intracanal medicament in the reduction of the levels of bacteria inside root canals of primary molar teeth with pulpal necrosis.

Enrollment

30 estimated patients

Sex

All

Ages

4 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Healthy children of both gender;
Without history of reactions or alergical diseases;
With situated age between 04 and 08 years of age
With normal standard of growth and development
Patients with necessity of radical endodontic treatment (pulpectomy) in, at least, two primary molar teeth in different hemi-arches.

Exclusion criteria

Patients with history of alergical diseases
Patients with allergy to any type of medicine and/or foods
Patients with comprometimento of its general state of health
Healthy patients with risk to develop bacterial endocardite or patients that their general state of health can be aggravated had the transitory bacteremies, as for example children with congenital cardiac illnesses
Patients who are making use of sistemis antibiotics, or that they have made use of sistemic antibiotic in the period of 3 (three) months before the beginning of the endodontic treatment
With periapical x-ray evidencing less than 2/3 of remaining root of the primary tooth to be treated
Patients whose tooth with endodontic necessity to meet in advanced state of root pathological reabsortion
Patients whose legal responsible or parents to refuse to sign the term of free and clarified assent